Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 4, 2024
The fatal case of "Pigmentibacter" bacteremia following aspiration pneumonia in elderly patientShigeru Azuma, Hitoshi Kawasuji, Ryosuke Nakai, et al.Internal Medicine (Tokyo, Japan)|January 16, 2008
Expression of the heparin-binding growth factor midkine in the cerebrospinal fluid of patients with neurological disordersYoshihiro Yoshida, Shinya Ikematsu, Hisako Muramatsu, et al.Journal of Cellular Physiology|October 18, 2016
p62 Promotes Amino Acid Sensitivity of mTOR Pathway and Hepatic Differentiation in Adult Liver Stem/Progenitor CellsMasakazu Sugiyama, Tomoharu Yoshizumi, Yoshihiro Yoshida, et al.Surgical Case Reports|February 3, 2017
Liver transplantation for cryptogenic liver failure caused by diffuse hepatic angiosarcoma: case reportYoshihiro Yoshida, Tomoharu Yoshizumi, Huanlin Wang, et al.Plos One|December 9, 2020
Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patientsHitoshi Kawasuji, Yusuke Takegoshi, Makito Kaneda, et al.Vaccine|June 5, 2024
Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4-5 vaccine and practical application of dried blood spotsHitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, et al.Journal of Medical Virology|August 19, 2021
SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, et al.Scientific Reports|August 17, 2021
Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, et al.Virology Journal|January 13, 2021
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike proteinHideki Tani, Miyuki Kimura, Long Tan, et al.Microbiology Spectrum|March 22, 2023
Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, et al.Pageof 8